Manganese based contrast agents as markers of beta cell activity in a preclinical model of type 1 diabetes mellitus

Project Details

StatusFinished
Effective start/end date8/02/16 → 31/12/17

Funding

  • UK industry, commerce and public corporations: £63,213.00